Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Biologics")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 593335

  • Page / 23734
Export

Selection :

  • and

The autoimmunologist : geoepidemiology, a new center of gravity, and prime time for autoimmunitySHOENFELD, Yehuda; SELMI, Carlo; ZIMLICHMAN, Eyal et al.Journal of autoimmunity (Print). 2008, Vol 31, Num 4, pp 325-330, issn 0896-8411, 6 p.Article

Monitoring Antigen-Specific Biologics: Current Knowledge and Future ProspectsZANDVLIET, Maarten L; VAN BEZOOIJEN, Jine S; BOS, Mariska A et al.Therapeutic drug monitoring. 2013, Vol 35, Num 5, pp 588-594, issn 0163-4356, 7 p.Article

Teledermatological Monitoring of Psoriasis Patients on Biologic TherapyKOLLER, Silvia; HOFMANN-WELLENHOF, Rainer; HAYN, Dieter et al.Acta dermato-venereologica. 2011, Vol 91, Num 6, pp 680-685, issn 0001-5555, 6 p.Article

Efficacy of Systemic Treatments for Moderate to Severe Plaque Psoriasis: Systematic Review and Meta-AnalysisBANSBACK, Nick; SIZTO, Sonia; HUIYING SUN et al.Dermatology (Basel). 2009, Vol 219, Num 3, pp 209-218, issn 1018-8665, 10 p.Article

The Sheffield rheumatoid arthritis health economic modelTOSH, Jonathan; BRENNAN, Alan; WAILOO, Allan et al.Rheumatology (Oxford. Print). 2011, Vol 50, issn 1462-0324, iv26-iv31, SUP4Conference Paper

Die immunmodulierende Therapie verbessert die Lebensqualität bei rheumatoider Arthritis : Lebensqualität bei rheumatischen Erkrankungen = Immunomodulatory therapy improves quality of life with rheumatoid arthritis : Quality of life in rheumatic diseasesGRANINGER, W.Zeitschrift für Rheumatologie (Print). 2010, Vol 69, Num 3, pp 210-212, issn 0340-1855, 3 p.Article

Rituximab use in everyday clinical practice as a first-line biologic therapy for the treatment of DMARD-resistant rheumatoid arthritisMCGONAGLE, D; TAN, A. L; MADDEN, J et al.Rheumatology (Oxford. Print). 2008, Vol 47, Num 6, pp 865-867, issn 1462-0324, 3 p.Article

Detection and evaluation of a drug safety signal concerning pancreatic cancer: lessons from a joint approach of three European biologics registersSTRANGFELD, Anja; HYRICH, Kimme; ZINK, Angela et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 1, pp 146-151, issn 1462-0324, 6 p.Article

The Knowns and Unknowns of Biologic Therapy in Ankylosing SpondylitisGENSLER, Lianne; INMAN, Robert; DEODHAR, Atul et al.The American journal of the medical sciences (Print). 2012, Vol 343, Num 5, pp 360-363, issn 0002-9629, 4 p.Conference Paper

Report on malignancies in the German juvenile idiopathic arthritis registryHORNEFF, Gerd; FOELDVARI, Ivan; MINDEN, Kirsten et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 1, pp 230-236, issn 1462-0324, 7 p.Article

Mechanisms of Adverse Drug Reactions to BiologicsCLARKE, Janet B.Handbook of experimental pharmacology. 2010, Vol 196, pp 453-474, issn 0171-2004, 22 p.Article

Etanercept at Different Dosages in the Treatment of Generalized Pustular Psoriasis : A Case SeriesESPOSITO, M; MAZZOTTA, A; CASCIELLO, C et al.Dermatology (Basel). 2008, Vol 216, Num 4, pp 355-360, issn 1018-8665, 6 p.Article

Infliximab then Efalizumab, the 'Hit and Run' Approach Does Not WorkBARDE, C; THIELEN, A. M; SAURAT, J.-H et al.Dermatology (Basel). 2008, Vol 216, Num 2, pp 171-172, issn 1018-8665, 2 p.Article

New-onset, debilitating arthritis in psoriasis patients receiving efalizumab : PsoriasisMYERS, Wendy A; NAJARIAN, David; GOTTLIEB, Alice B et al.Journal of dermatological treatment. 2006, Vol 17, Num 6, pp 353-354, issn 0954-6634, 2 p.Article

Biologics in development for rheumatoid arthritis : Relevance to osteoarthritisABRAMSON, Steven B; YAZICI, Yusuf.Advanced drug delivery reviews. 2006, Vol 58, Num 2, pp 212-225, issn 0169-409X, 14 p.Article

T cell targeted immunotherapy for autoimmune diseaseLEE, Erica; SINHA, Animesh A.Autoimmunity (Print). 2005, Vol 38, Num 8, pp 577-596, issn 0891-6934, 20 p.Article

Protein aggregation and lyophilization: Protein structural descriptors as predictors of aggregation propensityROUGHTON, Brock C; IYER, Lavanya K; BERTELSEN, Esben et al.Computers & chemical engineering. 2013, Vol 58, pp 369-377, issn 0098-1354, 9 p.Article

Genomics in mammalian cell culture bioprocessingWUEST, Diane M; HARCUM, Sarah W; LEE, Kelvin H et al.Biotechnology advances. 2012, Vol 30, Num 3, pp 629-638, issn 0734-9750, 10 p.Article

Outcomes of ileocolic resection and right hemicolectomies for Crohn's patients in comparison with non-Crohn's patients and the impact of perioperative immunosuppressive therapy with biologics and steroids on inpatient complicationsMASCARENHAS, Christopher; NUNOO, Robert; ASGEIRSSON, Theodor et al.The American journal of surgery. 2012, Vol 203, Num 3, pp 375-378, issn 0002-9610, 4 p.Article

Advances and challenges in analytical characterization of biotechnology products: Mass spectrometry-based approaches to study properties and behavior of protein therapeuticsKALTASHOV, Igor A; BOBST, Cedric E; ABZALIMOV, Rinat R et al.Biotechnology advances. 2012, Vol 30, Num 1, pp 210-222, issn 0734-9750, 13 p.Article

Neutrophil function in inflammation and inflammatory diseasesWRIGHT, Helen L; MOOTS, Robert J; BUCKNALL, Roger C et al.Rheumatology (Oxford. Print). 2010, Vol 49, Num 9, pp 1618-1631, issn 1462-0324, 14 p.Article

Biomarkersammlungen: Zukunft oder Ressourcenverschwendung? = Biomarkers collections. The future or a waste of resources?LORENZ, H.-M.Zeitschrift für Rheumatologie (Print). 2010, Vol 69, Num 10, pp 860-862, issn 0340-1855, 3 p.Article

Dosisanpassung bei Patienten mit rheumatoider Arthritis unter Therapie mit Infliximab in der rheumatologischen Versorgung in Deutschland : Ergebnisse aus dem Biologika-Register RABBIT = Dose adjustment in patients treated with infliximab in routine rheumatologic care in Germany. Results from the Biologies Register RABBITZINK, A; LISTING, J; STRANGFELD, A et al.Zeitschrift für Rheumatologie (Print). 2006, Vol 65, Num 5, pp 441-446, issn 0340-1855, 6 p.Article

Efficacy of anal fistula plug vs. fibrin glue in closure of anorectal fistulasJOHNSON, Eric K; GAW, Janette U; ARMSTRONG, David N et al.Diseases of the colon & rectum. 2006, Vol 49, Num 3, pp 371-376, issn 0012-3706, 6 p.Conference Paper

Acitretin revisited in the era of biologicsTE BOOIJ, MariËlle; VAN DE KERKHOF, Peter C. M.Journal of dermatological treatment. 2011, Vol 22, Num 2, pp 86-89, issn 0954-6634, 4 p.Article

  • Page / 23734